- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02480478
Serum Autotaxin Levels in Cholestasis of Pregnancy
April 19, 2016 updated by: Hakan Erenel, Sisli Hamidiye Etfal Training and Research Hospital
Diagnostic Accuracy of Serum Autotaxin Levels in Cholestasis of Pregnancy
Intrahepatic cholestasis of pregnancy is the most common liver disease in pregnancy.
It is is a pregnancy-specific liver disorder with onset mainly in the third trimester of pregnancy.
ICP is characterized by pruritus, elevated serum fasting bile salts and transaminases and an increased risk of adverse fetal outcomes.
Serum autotaxin levels were found highly sensitive and specific biomarker to to differentiate ICP from other pregnancy-related liver disorders or pruritic dermatoses.
The purpose of the study is to determine the diagnostic accuracy of serum autotaxin activity in cholestasis of pregnancy.
Study Overview
Status
Unknown
Conditions
Detailed Description
Collected data will enable us to compare serum autotaxin levels in cholestasis of pregnancy and healthy control group.
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hakan Erenel, MD,OBGYN
- Phone Number: 00905063092995
- Email: hakanerenel@yahoo.com
Study Locations
-
-
-
Istanbul, Turkey, 34371
- Recruiting
- Sisli Etfal Training and Research Hospital
-
Contact:
- Hakan Erenel, MD, OB/GYN
- Phone Number: 00905063092995
- Email: hakanerenel@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
patients who are admitted to obstetrics and gynecology department due to cholestasis of pregnancy
Description
Inclusion Criteria:
- Clinical diagnosed cholestasis of pregnancy patients
Exclusion Criteria:
- acute or chronic liver disease
- acute or chronic gallbladder disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
intrahepatic cholestasis of pregnancy
5 ml whole blood sample is going to collect from intrahepatic cholestasis of pregnancy group for the assessment of serum autotaxin levels
|
healthy control group
5 ml of whole blood is going to taken from healthy control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Serum autotaxin levels in cholestasis of pregnancy
Time Frame: one year
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Hakan Erenel, MD,OBGYN, Sisli Etfal Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Anticipated)
June 1, 2016
Study Completion (Anticipated)
January 1, 2017
Study Registration Dates
First Submitted
June 21, 2015
First Submitted That Met QC Criteria
June 23, 2015
First Posted (Estimate)
June 24, 2015
Study Record Updates
Last Update Posted (Estimate)
April 20, 2016
Last Update Submitted That Met QC Criteria
April 19, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 518
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intrahepatic Cholestasis of Pregnancy
-
Turku University HospitalCompletedPregnancy | Intrahepatic CholestasisFinland
-
University of BolognaWithdrawnIntrahepatic Cholestasis of PregnancyItaly
-
Epsom and St Helier University Hospitals NHS TrustKing's College Hospital NHS Trust; Medway NHS Foundation TrustUnknownPregnancy Complications | Intrahepatic Cholestases
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonUnknownIntrahepatic Cholestasis of Pregnancy | Cholestasis of Pregnancy | Obstetric CholestasisUnited Kingdom
-
Daping Hospital and the Research Institute of Surgery...maternal and child health hospital of Yong Chuan DistrictCompletedIntrahepatic Cholestasis of PregnancyChina
-
Zekai Tahir Burak Women's Health Research and Education...Unknown
-
Icahn School of Medicine at Mount SinaiWithdrawnIntrahepatic Cholestasis of Pregnancy
-
University Hospital, ToursCompletedIntrahepatic Cholestasis of PregnancyFrance
-
MetaboGen ABSkane University Hospital; Stockholm South General HospitalCompletedIntrahepatic Cholestasis of PregnancySweden
-
Peking UniversityNot yet recruitingCholestasis | Intrahepatic Cholestasis of PregnancyChina